BECN1 and hepatocellular carcinoma: Sorafenib could kill more HCC cells with improving antiproliferative ability when autophagy was repressed by chloroquine (CQ) or bafilomycin A1 or by a siRNA (small interfering RNA) against Beclin 1 or ATG5 [158].